
Sign up to save your podcasts
Or


In today's episode of the Innovation series, Dr. Parikh sits down with Mindy Mintz Mordecai, president and CEO of the Esophageal Cancer Action Network (ECAN). They discuss Mindy's journey, the origins of ECAN, and how it continues to support current and future patients with esophageal cancer. Today's episode was brought to you by Castle Biosciences, maker of TissueCypher, a test designed to predict the risk of esophageal cancer in patients with Barrett's esophagus.
By Neil D. Parikh, MD4.9
6262 ratings
In today's episode of the Innovation series, Dr. Parikh sits down with Mindy Mintz Mordecai, president and CEO of the Esophageal Cancer Action Network (ECAN). They discuss Mindy's journey, the origins of ECAN, and how it continues to support current and future patients with esophageal cancer. Today's episode was brought to you by Castle Biosciences, maker of TissueCypher, a test designed to predict the risk of esophageal cancer in patients with Barrett's esophagus.

32,238 Listeners

30,691 Listeners

4,412 Listeners

777 Listeners

3,378 Listeners

113,520 Listeners

8,869 Listeners

9,252 Listeners

7 Listeners

1,775 Listeners

10,218 Listeners

6,446 Listeners

26 Listeners

20,475 Listeners

2,323 Listeners